Inventiva Files 6-K for Jan 10 Press Release
Ticker: IVEVF · Form: 6-K · Filed: Jan 10, 2024 · CIK: 1756594
| Field | Detail |
|---|---|
| Company | Inventiva S.A. (IVEVF) |
| Form Type | 6-K |
| Filed Date | Jan 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: press-release, regulatory-filing, corporate-update
TL;DR
**Inventiva just filed a 6-K, likely sharing news from their January 10th press release.**
AI Summary
Inventiva S.A., a pharmaceutical company, filed a 6-K on January 10, 2024, to report a press release issued on the same date. This filing indicates that the company is providing public disclosure of information that was previously released, likely concerning an important update for investors. For shareholders, this matters because it signals that Inventiva is actively communicating material events, which can impact investor perception and potentially the stock's value.
Why It Matters
This filing confirms Inventiva is publicly disclosing information from a recent press release, which could contain updates on drug trials, financial performance, or strategic partnerships, all of which can influence investor decisions.
Risk Assessment
Risk Level: low — This 6-K filing itself is a routine disclosure of a press release and does not inherently introduce new risks, but rather points to information that may contain risks.
Analyst Insight
Investors should review the attached Exhibit 99.1 (the press release) to understand the specific material event Inventiva S.A. is disclosing, as this will contain the actual news that could impact the stock.
Key Players & Entities
- Inventiva S.A. (company) — the registrant filing the 6-K
- January 10, 2024 (date) — date of the press release and 6-K filing
- 001-39374 (other) — Commission File Number for Inventiva S.A.
FAQ
What is the purpose of Inventiva S.A.'s 6-K filing dated January 10, 2024?
The purpose of Inventiva S.A.'s 6-K filing dated January 10, 2024, is to report that the Registrant issued a press release on January 10, 2024, a copy of which is attached as Exhibit 99.1 and incorporated by reference.
What is Inventiva S.A.'s Commission File Number?
Inventiva S.A.'s Commission File Number is 001-39374, as stated in the filing.
Where are Inventiva S.A.'s principal executive offices located?
Inventiva S.A.'s principal executive offices are located at 50 rue de Dijon, 21121 Daix, France, with a business phone number of +33 3 80 44 75 00.
Under which form does Inventiva S.A. file its annual reports?
Inventiva S.A. indicates by check mark that it files its annual reports under cover of Form 20-F.
What is the exhibit number for the press release mentioned in the 6-K filing?
The press release dated January 10, 2024, is attached as Exhibit 99.1 to the 6-K filing.
Filing Stats: 186 words · 1 min read · ~1 pages · Grade level 9.5 · Accepted 2024-01-10 16:25:53
Filing Documents
- f6k_011024.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 21KB
- 0001171843-24-000200.txt ( ) — 26KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inventiva S.A. (Registrant) Date: January 10, 2024 /s/ Frdric Cren Frdric Cren Chief Executive Officer